Similar articles

• Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance.

  Gozal D, Hengy C, Fadat G. Gozal D, et al. Antimicrob Agents Chemother. 1991 Feb;35(2):373-6. doi: 10.1128/AAC.35.2.373. Antimicrob Agents Chemother. 1991. PMID: 2024970 Free PMC article. Clinical Trial.
• Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.

  Fogh S, Schapira A, Bygbjerg IC, Jepsen S, Mordhorst CH, Kuijlen K, Ravn P, Rønn A, Gøtzsche PC. Fogh S, et al. Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):820-2. doi: 10.1136/bmj.296.6625.820. Br Med J (Clin Res Ed). 1988. PMID: 3130927 Free PMC article. Clinical Trial.
• Malaria prophylaxis with proguanil in children living in a malaria-endemic area.

  Limsomwong N, Pang LW, Singharaj P. Limsomwong N, et al. Am J Trop Med Hyg. 1988 Mar;38(2):231-6. doi: 10.4269/ajtmh.1988.38.231. Am J Trop Med Hyg. 1988. PMID: 3281487 Clinical Trial.
• Prophylaxis against malaria for travellers from the United Kingdom. Malaria Reference Laboratory and the Ross Institute.

  Bradley D. Bradley D. BMJ. 1993 May 8;306(6887):1247-52. doi: 10.1136/bmj.306.6887.1247. BMJ. 1993. PMID: 8499856 Free PMC article. Review.
• Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.

  McKeage K, Scott L. McKeage K, et al. Drugs. 2003;63(6):597-623. doi: 10.2165/00003495-200363060-00006. Drugs. 2003. PMID: 12656656 Review.